V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 240002365 | 240005044 | null | 55.2 | Curative (C) | 2016-06-20 | 2016-06-20 | null | 02 | null | CNS LGG2004 03 VINC + CARBO | 101217456 |
| 240002366 | 240005045 | 1.74 | 84.3 | null | null | 2019-11-07 | Venetoclax | null | null | CYTARABINE + FLUDARABINE | 100189542 |
| 240002367 | 240005046 | 1.62 | 75 | null | null | 2016-07-02 | Methotrexate High Dose (3g/m2) | null | null | AML MYECHILD 01 A MITOZANTRONE/CYTARABINE | 101074915 |
| 240002368 | 240005047 | 1.8 | 77.6 | Disease modification (D) | 2017-06-13 | 2017-06-19 | Alemtuz+Fludara+Melphalan RIC MUD | 02 | null | NOT MATCHED | 100465735 |
| 240002369 | 240005048 | 1.8 | 19.3 | Curative (C) | 2019-11-13 | 2019-12-06 | Alemtuz+Fludara+Melphalan RIC MUD | N | N | BENDAMUSTINE + POLATUZUMAB VEDOTIN + RITUXIMAB | 100088320 |
| 240002371 | 240005050 | 1.85 | 29.2 | Curative (C) | 2016-06-12 | 2016-06-12 | CYTARABINE + METHOTREXATE + RITUXIMAB + THIOTEPA | 02 | null | CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB | 100978389 |
| 240002372 | 240005051 | 1.84 | 82 | null | 2018-12-23 | 2018-12-24 | RUXOLITINIB | 02 | N | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | 100078562 |
| 240002373 | 240005052 | 1.78 | 78 | Palliative (P) | null | 2016-08-04 | null | N | null | CISPLATIN + GEMCITABINE + RITUXIMAB | 101510083 |
| 240002375 | 240005054 | null | null | Curative (C) | null | 2020-01-07 | Trial Unspecified | null | N | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | 101013499 |
| 240002377 | 240005056 | 1.65 | 82 | Curative (C) | null | 2019-03-25 | ALL UKALL2011 Maintenance A1 | 01 | null | CYCLOPHOSPHAMIDE | 101605120 |
| 240002378 | 240005057 | 0 | 72.8 | null | null | 2016-09-13 | FLAIR trial | null | null | BUSULFAN | 100653402 |
| 240002380 | 240005059 | 1.66 | 79.4 | Curative (C) | 2018-05-07 | 2018-05-13 | CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB | 02 | null | CRIZOTINIB | 101097748 |
| 240002381 | 240005060 | 1.65 | null | Adjuvant (A) | null | 2018-08-11 | FLAG + Idarubicin | 02 | N | CYTARABINE + DAUNORUBICIN | 101194549 |
| 240002382 | 240005061 | 1.85 | 121.4 | Curative (C) | 2017-08-16 | 2018-02-11 | APML Relapse Reinduction ATO | N | null | PEG INTERFERON | 100799287 |
| 240002383 | 240005062 | null | 54.6 | Curative (C) | null | 2016-07-30 | AML MyeChild 01 IT Cyt | null | null | RUXOLITINIB | 101421066 |
| 240002385 | 240005064 | 1.85 | 21.6 | Palliative (P) | 2019-03-01 | 2019-03-07 | null | 02 | N | FLAG + IDARUBICIN | 101826085 |
| 240002386 | 240005065 | 1.52 | 17 | Curative (C) | 2016-01-10 | 2016-01-17 | null | 02 | N | ALL INT GDE 2019 MAINTENANCE | 100377782 |
| 240002387 | 240005066 | 1.58 | 89.2 | 03 | null | 2018-04-19 | AML MyeChild 01 FLA | null | N | AML MYECHILD 01 HD ARAC | 101201039 |
| 240002390 | 240005068 | 1.59 | 89.2 | Curative (C) | null | 2018-02-21 | TRANSPLANT CAR-T CELLS - AXICABTAGENE CILOLEUCEL | null | null | CARBOPLATIN + PACLITAXEL | 100782903 |
| 240002391 | 240005069 | 1.77 | 74.8 | Palliative (P) | 2019-02-07 | 2019-02-19 | Methotrexate intrathecal | 02 | N | DABRAFENIB | 101179262 |
| 240002394 | 240005072 | null | null | 03 | null | 2020-08-21 | DHAP - R | null | N | RUXOLITINIB | 100080664 |
| 240002397 | 240005074 | 1.63 | 76.55 | Curative (C) | 2016-04-02 | 2016-04-17 | DA-EPOCH-R | 02 | N | CYTARABINE + DAUNORUBICIN | 100514256 |
| 240002399 | 240005075 | 1.65 | 79.7 | Curative (C) | null | 2018-01-18 | GEMTUZUMAB OZOGAMICIN | null | N | IDELALISIB | 101433239 |
| 240002400 | 240005076 | 1.72 | 19.45 | Curative (C) | null | 2016-05-09 | AML MyeChild 01 HD AraC | 01 | N | CYCLOPHOSPHAMIDE | 101600440 |
| 240002401 | 240005077 | 1.5 | 57.7 | Curative (C) | null | 2020-08-16 | Alemtuz+Fludara+Melphalan RIC MUD | null | N | FLAIR TRIAL | 100808364 |
| 240002402 | 240005078 | 1.75 | 78.2 | null | null | 2016-12-28 | null | null | null | UKALL2011 | 100505549 |
| 240002403 | 240005079 | 1.69 | 26.5 | null | 2018-11-19 | 2018-12-03 | FLAG + Idarubicin | N | null | CAR-T AXICABTAGENE CILOLEUCEL + CYCLOPHOSPHAMIDE + FLUDARABINE | 100824587 |
| 240002404 | 240005080 | 1.6 | 83.9 | null | 2016-10-26 | 2016-11-29 | FLAIR trial | Y | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + ETOPOSIDE + RITUXIMAB + VINCRISTINE | 101815117 |
| 240002406 | 240005081 | 1.72 | 85.6 | null | 2018-10-26 | 2018-12-01 | AML MyeChild | null | null | AML MYECHILD 01 IT CYT | 101715564 |
| 240002408 | 240005082 | 1.7 | 53.9 | 03 | 2019-05-06 | 2019-05-06 | RUXOLITINIB | 01 | N | CYCLOPHOSPHAMIDE + ETOPOSIDE + PROCARBAZINE | 101831406 |
| 240002411 | 240005084 | 1.52 | 83 | null | null | 2016-09-24 | null | N | null | CARBOPLATIN + VINORELBINE | 101328817 |
| 240002414 | 240005086 | 1.76 | 68 | Curative (C) | null | 2018-10-17 | FLAIR trial | null | null | AML MYECHILD 01 FLA-IDARUBICIN | 100129461 |
| 240002415 | 240005087 | 1.6 | 77.6 | Curative (C) | 2018-09-20 | 2018-09-27 | AML MyeChild 01 FLA-Idarubicin | 02 | null | CISPLATIN + GEMCITABINE | 100564305 |
| 240002416 | 240005088 | 1.86 | 83.6 | Palliative (P) | null | 2016-03-07 | null | null | N | ALL UKALL2011 CONSOLIDATION A | 100182465 |
| 240002417 | 240005089 | 1.55 | 77.6 | Curative (C) | 2018-06-06 | 2018-08-09 | LIPOSOMAL DAUNORUBICIN + CYTARABINE (Vyxeos) | 01 | N | DABRAFENIB | 101782255 |
| 240002418 | 240005090 | 0 | 33.4 | Curative (C) | 2021-03-19 | 2021-05-27 | ANAGRELIDE | Y | null | VENETOCLAX | 100515222 |
| 240002419 | 240005091 | 1.72 | 58.8 | null | 2017-02-19 | 2017-03-19 | null | 02 | null | UKALL2011 | 101242152 |
| 240002420 | 240005092 | 1.57 | 15 | 03 | null | 2019-08-12 | BEAM | 02 | null | BUSULFAN | 101198817 |
| 240002421 | 240005093 | null | 96.5 | Curative (C) | null | 2018-11-17 | null | null | null | GILTERITINIB | 100148329 |
| 240002426 | 240005097 | 1.65 | 96.8 | Curative (C) | 2017-09-13 | 2017-09-13 | AML Interim Guidelines FLAG-Ida | 02 | N | CYCLOPHOSPHAMIDE + FLUDARABINE | 100918603 |
| 240002428 | 240005099 | 1.78 | 76 | 03 | 2016-09-26 | 2016-10-01 | Nilotinib | 02 | N | FLAG + IDARUBICIN | 101526696 |
| 240002430 | 240005101 | 1.68 | 16.2 | Curative (C) | 2017-11-20 | 2017-11-29 | TRANSPLANT ALEMTUZUMAB + CYCLOPHOSPHAMIDE (+/- TBI) | 02 | null | CARBOPLATIN + PEMETREXED | 100702960 |
| 240002431 | 240005102 | 1.55 | 64.3 | Curative (C) | null | 2020-02-19 | null | null | null | FLAG + IDARUBICIN | 101729725 |
| 240002432 | 240005103 | 1.86 | 96.4 | Palliative (P) | 2016-12-05 | 2016-12-11 | Venetoclax | 02 | N | BUSULFAN | 100120201 |
| 240002433 | 240005104 | 1.71 | 55 | Curative (C) | null | 2016-04-17 | CHLORAMBUCIL + OBINUTUZUMAB | null | N | UKALL2011 | 101072073 |
| 240002434 | 240005105 | 0 | 34.4 | Curative (C) | 2017-05-19 | 2018-03-12 | CARFILZOMIB | 01 | null | R-EPOCH | 100812746 |
| 240002438 | 240005108 | 1.73 | 107.9 | Not known (9) | 2019-05-18 | 2019-05-19 | IDELALISIB | 02 | null | FLAIR TRIAL | 101083728 |
| 240002440 | 240005109 | 1.7 | 70.15 | null | 2021-09-30 | 2022-04-12 | R-EPOCH | 01 | null | RUXOLITINIB | 100171381 |
| 240002441 | 240005110 | 1.7 | 128.6 | null | 2016-05-18 | 2016-05-25 | AML Downs AIE | 02 | null | METHOTREXATE + RITUXIMAB | 101005267 |
| 240002442 | 240005111 | 1.64 | 76 | null | 2018-05-14 | 2018-05-23 | Alemtuz+Fludara+Melphalan RIC MUD | 02 | null | CYCLOPHOSPHAMIDE + VINCRISTINE | 100798552 |